Skip to main content
Caplight Logo









GeneSys Bio

GeneSys Bio

Private
MontefiasconeHealthcare & Life Scienceshttps://genesysbio.com/

Last Round

Grant

Jun 1, 2024

Total Funding Raised

$260,700

Momentum

Top 5%

of companies Caplight tracks

Company Overview

GeneSys Bio is a biotechnology company that develops portable, AI-driven molecular diagnostic platforms for the rapid detection of pathogens and antibiotic resistance.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Medical AI, Environmental Monitoring

Business Model

B2B

Customer Profile

Hardware + Subscription, Subscription SaaS

AI Layer

Application

Keywords

molecular diagnosticspoint-of-care testingPOCTPCR diagnostic systempathogen detectionantimicrobial stewardshipclinical decision supportdiagnostic assay kitslab-on-a-chiprapid testingmedical deviceantibiotic resistancerazor and bladeshealth IoTdigital health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GeneSys Bio Comparables

Compare GeneSys Bio with similar companies based on industry and business-model similarity.

GeneSys Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Innotive Diagnostics
85%
Llusern Scientific
84%
Detechgene
83%

GeneSys Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 1, 2024
GrantMay 1, 2024
AcceleratorJul 1, 2023

Key People

Founding team and executive leadership

Andrea Faviere

Co-founder and CEO

Founding Team

Enrico Di Oto

COO

Executive Team

GeneSys Bio Investors

Notable investors and investment history

GeneSys Bio investors
InvestorRounds
AC75 Startup AcceleratorAccelerator
CDP Venture Capital SGRAccelerator
Lazio InnovaGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 202% MoM, reaching 2.4K.

  • Jun 19, 2026

    Monthly visitors increased 57% MoM.

GeneSys Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

GeneSys Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about GeneSys Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersMontefiascone
Employee Range5
Year Founded2023
Last FundingJun 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?